Abstract
Immunoinhibition assays are hypothesized to work by antibodies blocking substrate access to enzyme active sites. To test this hypothesis, the inhibition of amylase isoenzymes by monoclonal and polyclonal antisera was assessed using substrates of varying sizes: chromogenic sustrates 3, 5, or 7 glucose units in length, novel synthetic macromolecular substrates, and starch. The synthetic macromolecular substrates consisted of small oligosaccharide substrates linked to an inert polymer that conferred a large size to substrate molecules as determined by gel filtration chromatography. When substrate size increased, amylase activity could be inhibited equivalently by antibody concentrations that are 10‐fold lower. Progressively less polyclonal serum was required to inhibit amylase activity as substrate length increased from 3 to 5 to 7 glucose units and as size was increased by linkage to a polymer. Different effects of substrate size were observed with two monoclonal antibodies. One monoclonal antibody blocked amylase activity independent of substrate size, while another monoclonal antibody had little inhibitory effect except using starch as substrate. We conclude that use of larger substrates can expand the repertoire of inhibitory epitopes on enzymes and convert a noninhibitory antibody into an inhibitory one. J. Clin. Lab. Anal. 15:64–70, 2001.
Keywords: amylase, immunoassay, enzyme immunoassay, amylase isoenzymes, chromogenic substrates, macromolecular substrates
Published 2001 Wiley‐Liss, Inc. This article is a U.S. Government work, and, as such, is in the public domain in the United States of America.
references
- 1. Rubenstein KE, Schneider RS, Ullman EF. 1972. “Homogeneous” enzyme immunoassay: new immunochemical technique. Biochem Biophys Res Commun 47:846–851. [DOI] [PubMed] [Google Scholar]
- 2. Cinader B. 1965. In: Proceedings of the second meeting of the Foundation of European Biochemical Societies. Vienna: Oxford Pergamon; Vol 1 p 85–90. [Google Scholar]
- 3. Gibbons I, Skold C, Rowley GL, Ullman EF. 1980. Homogenous enzyme immunoassay for proteins employing &bgr;‐galactosidase. Anal Biochem 102:167–170. [DOI] [PubMed] [Google Scholar]
- 4. Skold C, Gibbons I, Russel ME, Juaristi E, Rowley GL, Ullman EF. 1985. Action of &bgr;‐galactosidase on novel synthetic macromolecular substrates. A processive enzymic reaction controlled by coulombic interactions. Biochim Biophys Acta 830:64–70. [DOI] [PubMed] [Google Scholar]
- 5. Rowley GL, Rubenstein KE, Huisjen J, Ullman EF. 1975. Mechanism by which antibodies inhibit hapten‐malate dehydrogenase conjugates. J Biol Chem 250:3759–3766. [PubMed] [Google Scholar]
- 6. Rosenthal AF, Vargas MG, Klass CS. 1976. Evaluation of enzyme‐multiplied immunoassay technique (EMIT) for determination of serum digoxin. Clin Chem 22:1899–1902. [PubMed] [Google Scholar]
- 7. Ooi DS, Maddock MJ, Livesey JF, Donnelly JG. 1996. Creatine kinase‐MB immunoinhibition in the diagnosis of suspected acute myocardial infarction. Clin Biochem 29:497–500. [DOI] [PubMed] [Google Scholar]
- 8. Gerber M, Naujoks K, Lenz H, et al. 1987. A monoclonal antibody that specifically inhibits human salivary &agr;‐amylase. Clin Chem 33:1158–1162. [PubMed] [Google Scholar]
- 9. Rauscher E, Gerber M. 1989. Pancreatic &khgr;‐amylase assay employing the synergism of two monoclonal antibodies. Clin Chim Acta 183:41–44. [DOI] [PubMed] [Google Scholar]
- 10. Gerber M, Naujoks K, Lenz H, et al. 1985. Specific immunoassay of &agr;‐amylase isoenzyme in human serum. Clin Chem 31:1331–1334. [PubMed] [Google Scholar]
- 11. Moss DW, Henderson AR. 1996. Enzymes In: Burtis CA, Ashwood ER, eds. Tietz fundamentals of clinical chemistry, 4 th ed. Philadelphia: WB Saunders; 283–335. [Google Scholar]
- 12. Winn‐Deen ES, David H, Sigler G, Chavez R. 1988. Development of a direct assay for &agr;‐amylase. Clin Chem 34:2005–2008. [PubMed] [Google Scholar]
- 13. Vissers RJ, Abu‐Laban RB, McHugh DF. 1999. Amylase and lipase in the emergency department evaluation of acute pancreatitis. J Emerg Med 17:1027–1037. [DOI] [PubMed] [Google Scholar]
- 14. Zakowski JJ, Bruns DE. 1985. Biochemistry of human alpha amylase isoenzymes [Review]. Crit Rev Clin Lab Sci 21:283–322. [DOI] [PubMed] [Google Scholar]
- 15. Mifflin TE, Hortin G, Bruns DE. 1986. Electrophoretic assays of amylase isoenzymes and isoforms. Clin Lab Med 6:583–599. [PubMed] [Google Scholar]
- 16. Rinderknecht H, Wilding P, Haverback BJ. 1967. A new method for the determination of alpha‐amylase. Experientia 23:805. [DOI] [PubMed] [Google Scholar]
- 17. Nishide T, Emi M, Nakamura Y, Matsubara K. 1984. Corrected sequences of cDNAs for human salivary and pancreatic alpha‐amylases. Gene 28:263–270. [DOI] [PubMed] [Google Scholar]
- 18. Rosenblum JL, Hortin GL, Smith CH, Pashos GE, Landt M. 1992. Macroamylases: differences in activity against various‐size substrates. Clin Chem 38:1454–1458. [PubMed] [Google Scholar]
- 19. Tarvers RC, Church FC. 1985. Use of high‐performance size‐exclusion chromatography to measure protein molecular weight and hydrodynamic radius. An investigation of the properties of the TSK 3000 SW column. Int J Pept Protein Res 26:539–549. [DOI] [PubMed] [Google Scholar]
- 20. Harris JM. 1992. Introduction to biotechnical and biomedical applications of poly(ethylene glycol) In: Harris JM, ed. Poly(ethylene glycol) chemistry, New York: Plenum Press; 1–14. [Google Scholar]
- 21. Squire PG. 1985. Hydrodynamic characterization of random coil polymers by size exclusion chromatography. Methods Enzymol 117:142–153. [DOI] [PubMed] [Google Scholar]
- 22. David H. 1982. Hydrolysis by human &agr;‐amylase of p‐nitrophenyl oligosaccharides containing four to seven glucose units. Clin Chem 28:1485–1489. [PubMed] [Google Scholar]
- 23. Brayer GD, Sidhu G, Maurus R, et al. 2000. Subsite mapping of the human pancreatic &agr;‐amylase active site through structural, kinetic, and mutagenesis techniques. Biochemistry 39:4778–4791. [DOI] [PubMed] [Google Scholar]